BBSRC Portfolio Analyser
Award details
Further development of an AAV vector production system exploiting novel AAV/HSV hybrids
Reference
E20016
Principal Investigator / Supervisor
Dr R Coffin
Co-Investigators /
Co-Supervisors
Dr Matthew Booth
,
Professor Adrian Thrasher
Institution
University College London
Department
Immunology and Molecular Pathology
Funding type
Research
Value (£)
160,357
Status
Completed
Type
Research Grant
Start date
01/10/2003
End date
30/09/2006
Duration
36 months
Abstract
This project aims to further develop production technology for AAV vectors through the use of HSV/AAV hybrids rather than the more commonly used adenovirus. This builds on previous BBSRC funded work where considerable progress was made. Clinical trials using AAV vectors are promising in e.g. haemophilia, but effective and scalable production technology is lacking. The aim of the project is to develop a robust and scalable production system not requiring transfection as is currently the case. We have generated HSV-based production systems overcoming various technical hurdles which now require further optimisation and development before up-scaling as required if HSV produced AAV vectors are to be used in pre-clinical and clinical studies.
Summary
unavailable
Committee
Closed Committee - Engineering & Biological Systems (EBS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
LINK: Engineering & Biological System Committee (EBL) [2000-2003]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search